Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents



Status:Completed
Conditions:Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:Any
Updated:3/7/2019
Start Date:October 1, 2012
End Date:April 30, 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Multicenter Cohort Study of the Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

This multicenter observational cohort study proposes to establish the risks of short and
long-term outcomes in users of parenteral micafungin and in users of other parenteral
antifungal agents from 2005 through 2012 with follow-up until 2017.

All eligible patients treated with a parenteral antifungal agent at any time during the years
2005-2012 in each of the participating hospitals, will be included in the study.

Inclusion Criteria:

- hospitalized and treated with parenteral antifungal medication

- first time treatment of the patient with parenteral antifungal in the medical center
was anytime from 2005 through 2012

Exclusion Criteria:

- prior diagnosis of hepatocellular carcinoma

- had received parenteral antifungal therapy during the 6 months prior to index
hospitalization
We found this trial at
6
sites
Site US6
Ann Arbor, Michigan 48109
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Site US4
Baltimore, Maryland 21205
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Site US2
Boston, Massachusetts 02119
?
mi
from
Boston, MA
Click here to add this to my saved trials
Site US3
Durham, North Carolina 27710
?
mi
from
Durham, NC
Click here to add this to my saved trials
Site US5
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Site US1
Pittsburgh, Pennsylvania 15213
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials